Recurrence of cerebrovascular events in young adults with a secundum atrial septal defect
Related Experiment Video
Updated: Jun 26, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Sjoukje I Lok1, Bjorn Winkens, Konstantinos Dimopoulos
1University of Maastricht, P.O. Box 616, 6200 MD Maastricht, The Netherlands.
Insights
Patients with atrial septal defect type 2 (ASD2) have a high risk of recurrent cerebrovascular events. Closing the defect appears to reduce this risk, but more research is needed.
Area of Science:
- Cardiology
- Neurology
- Medical Research
Background:
- The recurrence rate of cerebrovascular ischemic events in patients with atrial septal defect type 2 (ASD2) is unknown.
- Current treatment guidelines for ASD2 patients with prior cerebrovascular events are lacking.
Purpose of the Study:
- To determine the incidence rates of recurrent cerebrovascular events in patients diagnosed with ASD2.
Main Methods:
- A multicenter, retrospective study was conducted across the Netherlands, UK, and US.
- Patient data were gathered from medical files, electronic databases, and radiographic charts.
- Included were adult patients diagnosed with ASD2 and a history of cerebrovascular events.
Main Results:
- 19.6% of 56 recruited patients experienced recurrent events (9 TIA, 2 CVA) over a median follow-up of 5.3 years.
- The median age at the first cerebrovascular event was 37.5 years.
- Non-closure of the ASD2 was the sole significant predictor of recurrent events (p=0.01).
Conclusions:
- Patients with ASD2 and a history of cerebrovascular ischemic events face a substantial risk of recurrence.
- Closure of ASD2 may significantly lower the risk of recurrent events.
- Further prospective randomized trials are necessary to validate these findings.
Background:
The recurrence rate for cerebrovascular ischemic events in patients after a first TIA or CVA with an atrial septal defect type 2 (ASD2) remains unknown. At present, there are no guidelines with respect to appropriate treatment. The aim of this study was to determine incidence rates of recurrent cerebrovascular events in patients with ASD2.
Methods:
A multicenter, retrospective study was performed at selected centres in The Netherlands, United Kingdom and United States. All patients with ASD2 and a prior cerebrovascular event were identified from available databases. Clinical data were retrieved from medical files, electronic databases and radiographic charts.
Results:
Fifty-six adult patients born between 1950 and 1990 (median age at first cerebrovascular event 37.5, range 15-53 years) were recruited. Recurrent events (9 TIA, 2 CVA) were recorded in 11 patients (19.6%) during a median follow-up time of 5.3 years (range 0.2-28.9). Non-closure of the defect was the only significant predictor of a recurrent event (p=0.01).
Conclusion:
Patients with an ASD2 and a history of a cerebrovascular ischemic event have a substantial risk for recurrent events. Closure of the ASD2 seems to substantially decrease the risk of recurrence. However, prospective randomized trials are needed to confirm our findings.
More Related Videos
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Cerebral Edema ll: Pathophysiology
Aneurysm III: Interprofessional Care
Mitral Regurgitation I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis I: Introduction

